+
  • undefined
  • undefined

TE Test E 99.9% purity Testosterone Enanthate Test Prop 100% Safe Delivery

Product Name:Gonadorelin CAS:33515-09-2 Sequence:P-Glu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2 MF:C55-H75-N17-O13 MW:1182 Purity:above 98% Specification:2mg/vial, 10mg/vial Appearance:White Lyophilized Powder Method of Analysis: HPLC Storage: Lyophilized peptides although stable at room temperature for 3 months, should be stored desiccated below -18° C. Upon reconstitution of the peptide it should be stored at 4° C between 2-21 days and for future use below -18° C. Gonadorelin acetate Benefit Beofore we know the gonadorelin benefit,we need to know how gonadorelin work first. For evaluating the functional capacity and response of the gonadotropes of the anterior pituitary also for evaluating residual gonadotropic function of the pituitary following removal of a pituitary tumor by surgery and/or irradiation. Gonadorelin benefit:Gonadorelin is responsible for the release of follicle stimulating hormone and leutinizing hormone from the anterior pitutitary. In the pituitary GnRH stimulates synthesis and release of FSH and LH, a process that is controlled by the frequency and amplitude of GnRH pulses, as well as the feedback of androgens and estrogens. The pulsatility of GnRH secretion has been seen in all vertebrates, and it is necessary to ensure a correct reproductive function. Thus a single hormone, GnRH, controls a complex process of follicular growth, ovulation, and corpus luteum maintenance in the female, and spermatogenesis in the male. Its short half life requires infusion pumps for its clinical use Gonadorelin benefit:Systemic - Like naturally occurring gonadotropin-releasing hormone (GnRH), gonadorelin primarily stimulates the synthesis and release of luteinizing hormone (LH) from the anterior pituitary gland. Follicle-stimulating hormone (FSH) production and release is also increased by gonadorelin, but to a lesser degree. Gonadorelin benefit:In prepubertal females and some gonadal function disorders, the FSH response may be greater than the LH response. For the treatment of amenorrhea, delayed puberty, and infertility the administration of gonadorelin is used to simulate the physiologic release of GnRH from the hypothalamus in treatment of delayed puberty, treatment of infertility caused by hypogonadotropic hypogonadism, and induction of ovulation in those women with hypothalamic amenorrhea. This results in increased levels of pituitary gonadotropins LH and FSH, which subsequently stimulate the gonads to produce reproductive steroids. Gonadorelin benefit is mainly used in the clinical differential diagnosis of male or female reproductive disorders caused by hypothalamus or hypophysis, atrophic gonadal insufficiency, galactorrhea amenorrhea, primary and secondary amenorrhea, menopause and precocious menopause, pituitary tumor, pituitary organ damage and de facto hypothalamic dysfunction. It is a synthetic gonadotropin releasing hormone, which belongs to peptide compound and is decapeptide. The indications Gonadorelin benefit are as follows: 1. For the diagnosis of hypothalamus pituitary gonadal dysfunction. 2. To treat the infertility caused by amenorrhea, gonadotropin insufficiency and polycystic ovary. 3. Gonarelin or its analogues buserelin, goserelin, leuprorelin, nafarelin and triptorelin can also be used for contraception, cryptorchidism, malignant tumors (especially prostate cancer), delayed and early puberty. 4. It can also be used for endometriosis. 5. It is used for ovulation induction to treat infertility and primary ovarian insufficiency caused by hypothalamic amenorrhea, especially for patients with clomiphene ineffectiveness. 6. It is also used for cryptorchidism, androgen excess and pituitary tumor in children. The drug should be used under the guidance of a doctor. Gonadorelin bodybuilding Benefit As the Systemic - Like naturally occurring gonadotropin-releasing hormone (GnRH), gonadorelin primarily stimulates the synthesis and release of luteinizing hormone (LH) from the anterior pituitary gland,this Gonadorelin benefit also used by many bodybuilders to grow muscles. Gonadorelin Dosage for bodybuilding benefit Usually,If you are using it for the first time, the best initial Gonadorelin dosage is 2mg. As the body gradually adapts, increase the dose appropriately. 121062–08–6 MelanotanII 2381089–83–2 Retatrutide 189691–06–3 Bremelanotide 99291–20–0 V-9-M cholecystokinin nonapeptide 1208243–50–8 Poziotinib 307297–39–8 Epitalon 597562–32–8 LL-37 1627580–64–6 MOTS-c 75921–69–6 Melanotan 1 170851–70–4 Ipamorelin 189691–06–3 Bremelanotide 1401708–83–5 Dihexa 218949–48–5 Tesamorelin (usan) 137525–51–0 BPC 157

Classification:

Product Description

Testosterone was the first successfully synthesized anabolic steroid. Testosterone propionate is a fast-acting, short-ester, oil-based injectable testosterone compound that is commonly prescribed for the treatment of hypogonadism – low testosterone levels and various related symptoms in males.

Testosterone propionate was first described in 1935 to increase synthetic testosterone’s therapeutic usefulness by slowing its release into the bloodstream. It was released for clinical use two years later by Schering AG in Germany, featured in a hybrid blend with testosterone enanthate under the brand name Testoviron. This was also the first commercially available version on the U.S. prescription drug market and remained the dominant form of testosterone globally prior to 1960.

Cells in the adrenal cortex, ovary, and testis produce endogenous testosterone, the most common androgen in the human body. The treatment of either congenital or acquired hypogonadism involves the use of testosterone. The best exogenous androgen for postmenopausal women to use in the palliative management of breast cancer is testosterone. 1938 saw the introduction of testosterone, which the FDA approved in 1939. Anabolic steroids, which are testosterone derivatives, have been used illegally and are now considered restricted substances. In 1991, testosterone was designated as a restricted substance along with numerous anabolic steroids. Both standard and delayed-release (depot) dose versions of testosterone are supplied parenterally. In September 1995, the FDA initially approved testosterone transdermal patches (Androderm); many transdermal forms and brands are now available including implants, gels, and topical solutions. A testosterone buccal system, Striant, was FDA approved in July 2003; the system is a mucoadhesive product that adheres to the buccal mucosa and provides a controlled and sustained release of testosterone. In May 2014, the FDA approved an intranasal gel formulation (Natesto). A transdermal patch (Intrinsa) for hormone replacement in women is under investigation; the daily dosages used in women are much lower than for products used in males. The FDA ruled in late 2004 that it would delay the approval of Intrinsa women's testosterone patch and has required more data regarding safety, especially in relation to cardiovascular and breast health.

The propionate ester is a type of chemical molecule that reacts with water to form alcohols and organic or inorganic acids. The majority of esters are made from carboxylic acids, and one or more esters are frequently supplied along with injectable testosterone. The testosterone molecule has an ester added to it, which affects how soluble it is after it enters the bloodstream. A large/long ester will have a longer half-life; the longer the carbon chain, the longer the ester, and the less soluble the drug. In contrast, short carbon chains, such as the propionate ester, act quickly on the body and expel waste products at a similar rate. The testosterone ester has the shortest half-life of all testosterone esters, at 4 days, thanks to its three-carbon chain.